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The defining feature of the  subunits of the family of nico-
tinic acetylcholine receptors is a vicinal disulfide between Cys-
192 and Cys-193. Although this structure has played a pivotal
role in a number of pioneering studies of nicotinic receptors, its
functional role in native receptors remains uncertain. Using
mutant cycle analysis and unnatural residue mutagenesis,
including backbone mutagenesis of the peptide bond of the vic-
inal disulfide, we have established the presence of a network of
hydrogen bonds that extends from that peptide NH, across a 
turn to another backbone hydrogen bond, and then across the
subunit interface to the side chain of a functionally important
Asp residue in the non- subunit. We propose that the role of
the vicinal disulfide is to distort the turn and thereby properly
position a backbone NH for intersubunit hydrogen bonding to
the key Asp.
Nicotinic acetylcholine receptors (nAChRs)2 are neurotrans-
mitter-gated ion channels that mediate rapid synaptic trans-
mission throughout the central and peripheral nervous systems
(1–3). The nAChR family members are also the prototypes of a
large class of channels termed Cys-loop (or pentameric) recep-
tors, which are essential for learning,memory, and sensory per-
ception and are implicated in numerous neurological disorders,
including Alzheimer disease, Parkinson disease, and schizo-
phrenia (4, 5). Of the 17 genes that code for subunits of the
nAChR, 10 produce  subunits. The  subunits of nAChRs
typically contain the principal component of the agonist bind-
ing site and are distinguished by a unique vicinal disulfide at the
agonist binding site formed by residues canonically labeled as
Cys-192 and Cys-193. As shown in Fig. 1, the vicinal disulfide
produces an eight-membered ring that contains an amide and a
disulfide, two functionalities with distinct conformational
properties.
In the 1960s, reduction of this disulfide in the Electrophorus
electroplax led to the realization that the nAChR, long defined
as controlling the ion conductance of the membrane, is a pro-
tein (6–8). That this disulfide can be more easily reduced than
a typical protein disulfide was later rationalized by the finding
that the disulfide is vicinal and therefore embedded in a
strained ring (9, 10). The vicinal disulfide has been included and
discussed in many classic studies in early nAChR research
because of its susceptibility to reduction and proximity to the
agonist binding site (6, 7, 11–16).
Nevertheless, the precise role of the vicinal disulfide in
nAChR function is not established. Early studies (17) seemed to
indicate that reduction of this disulfide rendered the receptor
nonfunctional (but see below). Computational, NMR, and crys-
tallographic studies of model vicinal disulfides have probed the
multiple conformational possibilities of this unique structural
unit (18–22). The trans conformation that is overwhelmingly
preferred for backbone amides is expected to be disfavored in
the context of an eight-membered ring, allowing for an ener-
getically accessible cis backbone conformation. Also, a gauche
conformation is strongly preferred about the S–S disulfide
bond (C–S–S–Cdihedral angle90°). In the context of the ring
formed by the vicinal disulfide, the gauche() and gauche()
forms produce energetically distinct (diastereomeric) struc-
tures. The combined backbone and disulfide conformational
combinations give rise to four distinct conformers for the vici-
nal disulfide ring.
Although the sulfurs of the disulfide can contact small
molecules that bind to the acetylcholine-binding protein
(AChBP) (23, 24), a very useful model of the nAChR binding
site, any noncovalent interactions of this sort are expected to
be quite weak. Instead, many workers have speculated on a
role in receptor gating involving cis-trans isomerization of
the amide and/or gauche()/gauche() interconversion of
the disulfide (10, 18, 19, 21, 22). Conventional mutagenesis
studies are expected to produce severely impaired receptors,
and so it has been challenging to design unambiguous probes
of disulfide function.
Hereweuse subtle structural variations enabled by unnatural
amino acidmutagenesis to evaluate the possible functional role
of the vicinal disulfide of nAChR  subunits. We find evidence
that the vicinal disulfide contributes to an interesting triad of
residues that forms a network of hydrogen bonds that spans the
interface between two subunits and impacts receptor function.
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EXPERIMENTAL PROCEDURES
Preparation of Cysteine Analogs—Cysteine analogs were pre-
pared as 2-nitrobenzyl (NB) protected thiols. The 2-nitrobenzyl
group was removed via irradiation with 350-nm UV light
prior to injection into Xenopus oocytes. A synthesis of nitro-
veratryl-protected cysteine, needed for control experiments,
was described previously (25). Cyanomethyl esters ofN-MeCys
and -hydroxycysteine (Cah) were appended to the dinucle-
otide dCA, ligated to tRNA, and introduced to the nAChRs via
unnatural amino acidmutagenesis as described previously (26).
Synthesis of N-Me-N-NVOC-Cys(SNB)-OCH2CN—A 20-ml
scintillation vial was loaded with 4 ml of methanol and placed
over an ice water bath. To this was added 130mg (5.7 mmol) of
sodium. Themixture was stirred until themetal dissolved (20
min).N-Me cysteine (370mg, 2.7mmol), prepared as described
previously (27), was added to the vial, and the mixture was
stirred for 10 min. 2-Nitrobenzyl bromide (520 mg, 2.6 mmol)
was added in three portions to the stirring solution, turning a
clear solution into a cloudy mixture containing a pale yellow
precipitate. 1 h after the last addition, 20ml of chilled ether was
added. The precipitate was filtered, washed with 10 ml of
chilled ether, and dried to afford N-Me-Cys(SNB)-OH as a
crude, pale yellow solid. 100mg (0.37mmol) of this powder was
used directly in the next step without further purification. The
powder was suspended in 3 ml of water, and then an additional
1 ml of dioxane was added. Na2CO3 (59 mg, 0.56 mmol) was
added, and themixture was allowed to stir for 5min prior to the
addition of o-nitroveratryoxycarbonyl chloride (NVOC-chlo-
ride) (92 mg, 0.33 mmol) in 4 ml of dioxane. After stirring at
room temperature for 48 h, the solution was diluted with 10 ml
of CH2Cl2 and 10ml of water. The organic layer was discarded,
and the pH of the aqueous layer was decreased to 1 via the
addition of 6 MHCl. Following extractionwith CH2Cl2, the new
organic layer was dried over Na2SO4 and poured over a silica
plug. The plug was rinsed with 25 ml of EtOAc and then eluted
with 2% AcOH in EtOAc. The yellow eluent was concentrated
to reveal N-Me-N-NVOC-Cys(SNB)-OH as a pale yellow solid
in 84% yield (158 mg, 0.310 mmol). Rf  0.34 (2% AcOH in
EtOAc); 1HNMR (300MHz, CDCl3, 298 K)  7.89 (1H,m), 7.63
(1H, m), 7.47 (1H, t, J 7.5 Hz), 7.36 (2H, m), 6.89 (1H, d, J
14.1 Hz), 5.50 (2H, m), 4.68 (1H, m), 4.04 (2H, s), 3.86 (6H, s),
2.81–3.04 (5H, m); 13C NMR (75 MHz, CDCl3, 298K)  177.7,
174.9, 156.4, 153.7, 147.9, 139.3, 133.4, 133.2, 132.1, 128.6,
128.3, 125.6, 109.1, 108.1, 64.7, 58.9, 56.4, 56.4, 33.5, 32.3, 30.9;
high-resolution MS analysis (FAB)m/z: calculated 510.1182,
found 510.1180.
N-Me-N-NVOC-Cys(SNB)-OH (58 mg, 0.11 mmol) was
added to a 2-ml scintillation vial and suspended in 0.35 ml of
chloroacetonitrile (5.5 mmol). Triethylamine (50 ml, 0.33
mmol) was added to themixture, and the resulting solutionwas
stirred for 4 h. The solutionwas dilutedwith 15ml of water, and
the organic layer was extracted with CH2Cl2 (3), dried over
Na2SO4, and concentrated to yield a yellow oil. The oil was
purified by flash column chromatography on silica gel (50%
EtOAC in hexanes) to afford N-Me, N-NVOC-Cys-(SNB)-
OCH2CN as a yellow oil in 62% yield (37mg, 0.067mmol). Rf
0.25 (50% EtOAc in hexanes); 1H NMR (300 MHz, CDCl3, 298
K)  7.98 (1H, m), 7.70 (1H, m), 7.54 (1H, m), 7.43 (2H, m), 6.95
(1H, d, J 14.1Hz), 5.55 (2H,m), 4.72 (3H,m), 4.08 (2H, s), 4.00
(3H, s), 3.95 (3H, s), 2.89–3.10 (5H, m); 13C NMR (75 MHz,
CDCl3, 298K)  168.5, 156.1, 153.7, 148.1, 133.3, 133.3, 133.2,
132.1, 128.7, 128.7, 127.9, 125.6, 109.5, 108.2, 64.9, 59.0, 56.4,
56.4, 49.1, 33.6, 32.7, 31.0; high-resolutionMS analysis (FAB)
m/z: calculated 549.1291, found 549.1302.
Synthesis of HO-Cys(SNB)-OCH2CN—The synthesis of 2-ni-
trobenzyl protected-hydroxycysteinewas based on a protocol
reported by Kelly and co-workers (28). (2-Nitrophenyl)meth-
anethiol (400 mg, 3.9 mmol) was prepared as described previ-
ously (29) and added to a flame-dried 50-ml, two-neck, round
bottom flask equippedwith a reflux condenser and under argon
(g). To this was added methyl-(2S)-glycidate (660 mg, 3.9
mmol), triethylamine (0.54ml, 3.9 mmol), and 20ml ofMeOH.
Themixture was stirred for 5 h at reflux until completion of the
reaction as determined by TLC. After cooling to room temper-
ature, themixture was concentrated in vacuo, and the resulting
yellow oil was purified by flash column chromatography on
silica gel (25%EtOAc in hexanes) to affordHO-Cys(SNB)-OMe
in 35% yield (370 mg, 1.4 mmol). Rf  0.44 (50% EtOAc in
hexanes); 1H NMR (300MHz, CDCl3, 298 K)  7.98 (1H, d, J
8.2 Hz), 7.39–7.59 (3H, m), 4.44 (1H, b), 4.19 (2H, s), 3.79 (3H,
s), 3.15 (1H, b), 2.89 (1H, dd, J 14.4, 4.7 Hz), 2.75 (1H, dd, J
14.4, 6.4 Hz); 13C NMR (75 MHz, CDCl3, 298K)  173.5, 148.6,
133.8, 133.0, 132.2, 128.3, 125.5, 71.2, 52.9, 35.3, 34.1; high-
resolutionMSanalysis (FAB)m/z: calculated 272.0593, found
272.0591.
HO-Cys(SNB)-OMe (44mg, 1.6mmol) was added to a 20-ml
scintillation vial and dissolved in 10 ml of 1 M LiOH in 3:1:1
tetrahydrofuran:methanol:water. The mixture was stirred for
12 h at room temperature. The pH of the solution was adjusted
to pH 12 via the addition of 2 M NaOH. The aqueous layer was
washedwith 30ml of ether, and the organic layerwas discarded.
The pH of the aqueous layer was decreased to 1 via the addition
of 6 M HCl and extracted with EtOAc. The new organic layer
waswashedwith brine, dried overNa2SO4, and concentrated to
yield HO-Cys(SNB)-OH as a yellow oil in 85% crude yield (350
mg, 1.4 mmol). Cyanomethyl esterification began with the
addition of HO-Cys(SNB)-OH (250 mg, 0.97 mmol) to a 4-ml
scintillation vial. Chloroacetonitrile (0.5 ml, 7.9 mmol) and tri-
ethylamine (0.40 ml, 2.9 mmol) were added to the vial, and the
mixture was stirred for 12 h. The solution was diluted with 15
ml of water, and the organic layer was extracted with CH2Cl2
(3), dried over Na2SO4, and concentrated to a yellow oil. The
oil was purified by flash column chromatography on silica gel
(50% EtOAC in hexanes) to afford HO-Cys(SNB)-OCH2CN as
a yellow oil in 55% yield (160 mg, 0.53 mmol). Rf  0.35 (50%
EtOAc in hexanes); 1H NMR (400 MHz, CDCl3, 298 K)  7.95
(1H, d), 7.39–7.57 (3H,m), 4.78 (2H,m), 4.52 (1H,m), 4.16 (2H,
dd, J 19.2, 13.3 Hz), 3.26 (1H, d, J 5.5 Hz), 2.91 (1H, dd, J
14.5, 3.9 Hz), 2.78 (1H, dd, J  14.6, 5.9 Hz); 13C NMR (100
MHz, CDCl3, 298K)  171.4, 148.6, 133.4, 133.2, 132.2, 128.5,
125.5, 113.8, 71.0, 49.3, 35.1, 34.2; high-resolution MS analysis
(FAB)m/z: calculated 297.0545, found 297.0546.
Mutagenesis—Both conventional and unnaturalmutagenesis
were performed on mouse muscle embryonic nAChR
(121) cDNA in the pAMVvector using the standard Strat-
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ageneQuikChange protocol. For unnatural mutagenesis, a stop
codon, TAG or TGA, was made at the site of interest and veri-
fied through sequencing. The  subunit contained a back-
ground mutation in the M2 transmembrane helix (L9S) that
is known to lower whole-cell EC50 values (30, 31). The 1 sub-
unit also contains a hemagglutinin epitope in theM3-M4 cyto-
plasmic loop. This epitope does not alter EC50 values in control
experiments. cDNAwas linearized with the restriction enzyme
NotI. mRNA was prepared by in vitro transcription using the
mMessage mMachine T7 kit (Ambion, Austin, TX).
Stage V-VIXenopus laevis oocytes were injectedwithmRNA
in a 2:1:1:1 or 10:1:1:1 ratio of 1:1:: for conventional or
unnatural amino acid mutagenesis experiments, respectively.
Hydroxy or amino acids were appended to the dinucleotide
dCA and enzymatically ligated to the truncated 74-nucleotide
THG73 or TQOpS tRNA as described previously (26). NVOC
and 2-nitrobenzyl protecting groups on the appended amino or
-hydroxy acids were removed by irradiation with UV light
filtered to 350 nm. For conventional experiments, 1–2 ng of
mRNA was injected per oocyte in a single 75-nl injection. For
unnatural amino acid experiments, each cell was injected with
75 nl of a 1:1 mixture of mRNA (20–25 ng of total mRNA) and
tRNA (20–30 ng).Oocyteswere incubated at 18 °C for 24–48 h
after injection. Wild-type recovery experiments (injection of
tRNA appended to the natural amino acid) were performed to
evaluate the fidelity of the unnatural suppression experiments.
Additional controls, injections of mRNA only and mRNA with
76-mer THG73 or TQOpS, were also performed. Although
currents were seen for 76-mer control experiments, EC50 and
Hill values were distinct from the values obtained for 74-mer
ligated to an -hydroxy or amino acid. Conventional experi-
ments with 42 (32) and 44 and 7 (33) were performed as
described previously.
Electrophysiology—The functional effects of mutation were
evaluated using two-electrode voltage clamp electrophysiology.
Electrophysiology experiments were performed 24–48 h after
injection using the OpusXpress 6000A instrument (Axon
Instruments) at a holding potential of 60 mV. A Ca2-free
ND96 solution was used as the running buffer (96 mM NaCl, 2
mMKCl, 1mMMgCl2, and 5mMHEPES, pH 7.5). Acetylcholine
doses in Ca2-free ND96 were applied for 15 s followed by a
116-s wash with the running buffer. Dose-response data were
obtained for 8 agonist concentrations on 7 cells. All EC50
and Hill coefficient values were obtained by fitting dose-re-
sponse relations to the Hill equation and are reported as aver-
ages  S.E. of the fit. A detailed error analysis of nonsense
suppression experiments shows that data are reproducible to
50% in EC50 (34).
Ab Initio Calculations—Structure building and subsequent
ab initio calculations on CH3CO-[Cys-Cys]-NH2 were carried
out using the Gaussian 03 software package (35) at the B3LYP/
6–311G(d,p) level of theory in the gas phase. The cis and
trans isomers of a model peptide of the form CH3CO-[Cys-
Cys]-NH2 with the S–S disulfide torsional angles of 90 were
constructed using the GausView molecule building tools. The
geometric parameters for these starting structureswere derived
from the lowest energy conformers from previous ab initio cal-
culations on a similar model peptide (21). Energy minimiza-
tions were performed on the four starting structures of the
model peptide. The lowest energy structures from these model
peptide calculations then served as scaffolds for constructing the
initial ester and N-methyl structures, which were subsequently
subject to energy minimization calculations. In total, the energies
for 12 geometry-optimized structures were calculated, with four
conformers for eachmodel system. Further details are provided in
Ref. 36. Calculations on simple cyclic amides and related struc-
tures were performed with SPARTAN (37).
RESULTS
Conformational Analysis and Experimental Design—As
noted above, both the disulfide and the amide functionalities
have two distinct conformations. In the computational studies
described below, the gauche() and gauche() forms of the
disulfide are very similar in energy and seem unlikely to play a
strong discriminating role. Our work has emphasized the
gauche() as this is the conformation seen in AChBP crystal
structures.
For the amide unit, the issue is cis-trans isomerization. In a
typical protein, a backbone amide shows a strong preference for
the trans conformation (if proline is not involved). However,
incorporation into an eight-membered ring is expected to favor
the cis form. This expectation derives from studies of the con-
formational preferences of small molecules. For example, in
cyclooctene, the trans form is substantially strained, and the cis
form is preferred. Ab initio calculations we have performed show
that an amide in an eight-membered alkane ring also shows apref-
erence for cis; at the HF-6–31G** level of theory, N-methylacet-
amide shows a 2.5 kcal/mol preference for trans, whereas the
cyclic amide shows a 5.4 kcal/mol preference for cis.
More sophisticated calculations at the B3LYP/6–
311G(d,p) level of theory on a model tripeptide (CH3CO-
[Cys-Cys]-NH2, Fig. 1) for the nAChR vicinal disulfide likewise
show an energetic preference for the cis amide, by 3.4 kcal/mol.
This is not a large energy difference, and indeed, both cis and
trans forms have been seen in crystal structures of molecules
that contain a vicinal disulfide (38, 39). As such, it is reasonable
to consider that perhaps cis-trans isomerization of theCys-192-
Cys-193 backbone may play a role in gating of nAChRs (10, 18,
19, 21, 22). This structural change could then easily be imagined
to propagate along the protein backbone and perhaps initiate
the “conformational wave” (40) that leads to gating.
To test this model, we sought modifications to the vicinal
disulfide that would alter the innate cis-trans bias of the system.
FIGURE 1.Vicinal disulfide structure. Formodel calculations of CH3CO-[Cys-
Cys]-NH2, R1  CH3 and R2  H. Also shown are the unnatural amino acids
(N-Methyl Cys and Cah) used in this study.
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For example, it is well known (41) that esters have a stronger
trans preference than amides; methyl acetate prefers trans by
8.0 kcal/mol when compared with the 2.5 kcal/mol noted for
N-methylacetamide above. It is also well established that
N-methylation reduces the innate trans preference of a back-
bone amide in peptides and proteins (42, 43). Thus, we consid-
ered the strategy of modifying the amide linkage of the vicinal
disulfide. If cis-trans isomerization of this unit plays a role in
receptor function, then the ester and N-methyl modifications
should have opposite effects.
To test this prediction in silico, we performed comparable
B3LYP/6–311G(d,p) calculations on the ester and N-
methyl amide analogs of the vicinal disulfide model discussed
above. The results are consistent with expectations based on
the conformational preferences of small molecules discussed
above. When compared with the natural backbone (an amide),
which favors the cis by 3.4 kcal/mol, the ester favors the trans by
1.4 kcal/mol.N-Methylation increases the cis preference of the
parent (the amide backbone) to 9.3 kcal/mol, consistent with
experimental studies on a similar system reported by Hondal
and co-workers (22).
It is difficult to apply these data to nAChR function in a quan-
titative way; calculations were performed on model tripeptides
and depsipeptides in the gas phase, not on an 2.5-MDa pen-
tameric, polytropic receptor protein in a cell membrane. How-
ever, the predictions of the calculations are clear. If cis-trans
isomerization of the vicinal disulfide amide is functionally
important, the two modifications considered, backbone ester
incorporation and amide N-methylation, should have opposite
effects on receptor function.
Both modifications can be site-specifically introduced into
the nAChR using the in vivo nonsense suppression methodol-
ogy that has been developed in our laboratories over the past 20
years (44, 45). We thus set out to prepare and characterize the
appropriate mutant receptors as a test of the computational
modeling.
Mutagenesis Studies—Initial control experiments involving
the vicinal disulfide clarified the effect of eliminating this struc-
ture.We found thatwe could introduceAla or Ser at Cys-192 or
Cys-193 of the wild-type muscle subtype receptor and obtain
functional receptors. The EC50 value shifts8–40-fold (Table
1), and current sizes comparable with those for the wild-type
receptor are seen. We repeated these studies in three other
subtypes of the nAChR, the neuronal receptors 42, 44,
and7, and saw similar effects butwith generally larger shifts in
EC50 (20–200-fold, supplemental Table S1).
In 1985, Mishina et al. (17) reported that C192S and C193S
mutants of Torpedo nAChR, a close paralog of the muscle
nAChR, were unresponsive to high concentrations of ACh but
did bind -bungarotoxin. These findings suggested that muta-
tion of either residue results in a receptor that is properly folded
but does not function. However, our present finding that the
nAChR can be activated even in the presence of mutated 192
and 193 side chains indicates that the vicinal disulfide linkage
increases the efficiency of receptor function but is not abso-
lutely required.
In these studies, we are reporting EC50 values, a functional
measure that includes contributions from both ligand bind-
ing and receptor gating. For the residues emphasized here,
there is no evidence that Cys-192 and Cys-193 interact
strongly and directly with agonists, and so we anticipate that
mutations primarily impact receptor gating, although we
cannot prove that unambiguously. In the upcoming discus-
sion, we will be describing the results of mutant cycle anal-
ysis studies. It is standard practice in that field to convert
coupling interactions (nonadditivity) to free energies (G°)
(46, 47). In view of this, and solely for the purpose of discus-
sion, we will put all changes in EC50 values on a similar
energy scale: G°  RTln(EC50(mutant)/EC50(wild type)).
Before launching detailed nonsense suppression experi-
ments with N-methyl Cys and Cah (cysteine, -hydroxy) we
considered several conditions and nAChR subtypes, including
the muscle receptor 121 and the neuronal subtypes 42,
44, and 7.We chose to focus on the muscle subtype for the
following reasons. The muscle subtype is, in general, the most
studied nAChR, and it is also the receptor that gave the highest
currents for nonsense suppression experiments withN-methyl
Cys and Cah. In addition, it has a defined stoichiometry, a sub-
stantial advantage over the 42 and 44 receptors (which
each have two possible subunit stoichiometries). It also
required considerably lower agonist concentrations than those
needed for experiments with 7.
For our nonsense suppression experiments in 121, we
used the well documented leucine-to-serine mutation at the 9
position in theM2 region of nAChR. Thismutation renders the
nAChR40 times more sensitive to agonists, as judged by the
decrease in EC50 (30, 31). The 9 position lies some 60 Å from
the agonist binding site and from the vicinal disulfide studied
TABLE 1
EC50, Hill coefficient ( S.E.), andG° values for mutations made to 121
Mutation EC50 Hill G°
M kcal/mol
11 18 0.2 1.4 0.01
1(C192A)1 660 20 1.3 0.05 2.1
1(C192S)1 520 20 1.5 0.08 2.0
1(C193A)1 140 3 1.2 0.02 1.2
1(C193S)1 150 7 1.4 0.07 1.3
1(L9S) 0.61 0.04 1.4 0.1
1(S191A)1(L9S) 0.31 0.02 1.1 0.05
1(S191A/C193A)1(L9S) 5.2 0.4 1.0 0.07 1.7
1(S191A/C193S)1(L9S) 9.5 0.7 0.96 0.06 2.0
1(S191A/C193Cah)1(L9S) 49 4 0.80 0.03 3.0
1(S191A/C193(N-methyl Cys))1(L9S) 39 2 0.88 0.04 2.9
1(S191Aah)1(L9S) 31 3 1.1 0.09 2.7
1(S191A)1(L9S)(D174N)(D180N) 160 7 1.3 0.06 3.7
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here, and therefore it does not directly affect the Cys-192-Cys-
193 region but instead affects receptor gating. This change
favors the open state of the channel once an agonist molecule
has bound, also increasing the efficacy of some agonists.
We also introduced a mutation in the 1 subunit, S191A, of
all mutant proteins used in doublemutant cycle analyses as this
mutant promotedmore reliable current sizes for nonsense sup-
pression experiments with -hydroxy acids at position 191,
experiments that will be discussed in greater detail below. We
showed previously (48) that the S191A mutation has a minor
effect on receptor function (see also Table 1) and that the incor-
poration of Aah (-hydroxyalanine) or Sah (-hydroxyserine)
at Ser-191 results in the same EC50 shift.
In the crucial experiments involving alteration of the back-
bone of the Cys-192-Cys-192 unit, we find that replacement of
Cys-193, whose backbone is within the eight-membered ring
formed by the vicinal disulfide, with either N-methyl Cys or
Cah produces similar results. Both mutations are loss-of-func-
tion, and their impacts are comparable in magnitude, with a
G° value of3 kcal/mol. These are relatively large effects for
such subtle mutations (larger than the Cys-to-Ala mutations),
suggesting an important functional role for the backbone of
Cys-193. These results are not consistent with a functional role
for cis-trans isomerization, which predicts opposite effects for
the two modifications.
Although differing in their anticipated impact on cis-trans
isomerization, the two backbone mutations are similar in
another regard; both ablate the hydrogen bond-donating ability
associated with the NH of the parent amide. An inspection of
AChBP structures reveals a potential acceptor for such a hydro-
gen bond donor: the carbonyl of residue Tyr-190, a conserved
member of the agonist binding site. This hydrogen bond is gen-
erally present in AChBP structures, and it defines a distorted
Type I  turn, with Tyr-190, Ser-191, Cys-192, and Cys-193
being residues i to i3, respectively (Fig. 2).
The inclusion of Ser-191 in the turn suggested amore com-
plex interaction than just a simple hydrogen bond. Previous
work from our laboratories (48) strongly supported a model in
which the backbone NH of Ser-191 makes an intersubunit
hydrogen bond to the side chain of a critical Asp in the /
subunits (Asp-174/Asp-180). This hydrogen bond contrib-
utes to ion channel gating. In that study, we removed the critical
NH by preparing the mutant S191Sah or S191Aah, producing
one of the largest perturbations ever observed in our laborato-
ries for the introduction of a backbone ester. A double mutant
cycle analysis combining S191Sah and D174N/D180N pro-
vided strong functional evidence for an interaction, with a cou-
pling energyG° 2.7 kcal/mol. However,many studies have
shown that a backbone estermutation not only removes a back-
bone NH that can donate a hydrogen bond, it also weakens the
hydrogen bond-accepting ability of the associated i-1 carbonyl
(49–54). For Ser-191, the i-1 carbonyl comes fromTyr-190, the
carbonyl implicated in the hydrogen bond of the  turn dis-
cussed above. Could the S191Sah effect be so large because it
both deletes the hydrogen bond to Asp-174/Asp-180 and
weakens an important  turn hydrogen bond?
We have now found support for the turn hydrogen bond. A
mutant cycle analysis (Fig. 3A) combining S191Aah and
C193(N-methyl Cys) shows a strong coupling energy, with
G° 2.7 kcal/mol (Table 2). This finding supports the exis-
tence of a novel, 3-residue, hydrogen bond network, in which
the NH of Cys-193 hydrogen bonds to the carbonyl of the pep-
tide bond between Tyr-190 and Ser-191. In addition, the NH of
the Tyr-190-Ser-191 peptide bond hydrogen-bonds to the side
chain of Asp-174/Asp-180 (Fig. 3).
If this hydrogen-bonding network exists, energetic cou-
pling between the NH of Cys-193 and the side chain of Asp-
174/Asp-180 is expected. Indeed, we find strong coupling
energies between the D174N/D180N mutation and either
C193(N-methyl Cys) or C193Cah, with G° values of 2.0
and 2.2 kcal/mol (Table 2, Fig. 3B). The magnitude of this
interaction is quite significant when one considers the link-
age is from a residue in the  subunit, through a second
residue in the  subunit, and then across the subunit inter-
face to a residue in the / subunit.
These results suggest a key role for the peptide bond of the
Cys-192-Cys-193 unit. In support of this view, mutations that
remove the disulfide but keep the peptide bond are much less
impactful. Mutant cycles that link C193A to the backbone NH
of Ser-191 or to D174N/D180N produce G° coupling
energies of 0.99 and 0.80 kcal/mol, respectively, clearly smaller
than seen with backbone mutations.
DISCUSSION
The present work began as an effort to evaluate a possible
role for cis-trans isomerization of the Cys-192-Cys-193 peptide
bond embedded in the unusual vicinal disulfide of the  sub-
units of nAChRs. Our data do not support such a transition, but
instead reveal an extended network of hydrogen bonds that
appears to play a significant role in receptor function. In this
network, the backbone NH of Cys-193 hydrogen-bonds to the
backbone carbonyl of Tyr-190. The Tyr-190 carbonyl is, in
turn, connected to the NH of Ser-191, which hydrogen-bonds
across the subunit interface to the side chain of Asp-174/
Asp-180. Themodel is strongly supported by long-range dou-
blemutant cycle analysis that links theD174N/D180Nmuta-
tion to Cys-193 backbonemutations. Removing theNHof Cys-
FIGURE 2. The turn found in AChBP structures. The structure is from Pro-
tein Data Bank (PDB) file 1UV6 (24) and was modified to contain an Ala at
Ser-191.(24) The side chain of Tyr-190 is truncated (replacedwith a hydrogen)
for simplicity.
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193 either by ester incorporation or byN-methylation produces
the same effect: a coupling energy G° of 2.0–2.2 kcal/mol to
the Asp-to-Asn mutations.
The  turn hydrogen bond between the carbonyl of Tyr-190
and theNHof Cys-193was suggested byAChBP structures (23,
24). Note, however, that the second hydrogen bond of the triad,
that between the NH of Ser-191 and the side chain of Asp-
174/Asp-180, is not present in AChBPs and represents a sig-
nificant difference between the actual nAChRs and the model
AChBP systems. In fact, in crystal structures of AChBP, the
FIGURE 3.Doublemutant cycle analysis. A, coupling between backbonemutations at Ser-191 and Cys-193. Note that introduction of the -hydroxy
acid at Ser-191 attenuates the hydrogen bond acceptor for the hydrogen bond with Cys-193 and removes the hydrogen bond donor for the hydrogen
bond to Asp-174/Asp-180. B, long-range coupling between a backbone mutation at Ser-191 and a side chain mutation at Asp-174/Asp-180.
TABLE 2
EC50, Hill coefficient ( S.E.), andG° values for double mutations made to 121
Double mutation EC50 Hill G°
M kcal/mol
1(S191Aah/C193A)1(L9S) 97 10 0.76 0.04 0.99
1(S191Aah/C193S)1(L9S) 100 7 0.93 0.05 1.3
1(S191Aah/C193(N-methyl Cys))1(L9S) 39 4 0.70 0.03 2.7
1(S191Aah)1(L9S)(D174N)(D180N) 140 10 1.7 0.2 2.8
1(S191A/C193A)1(L9S)(D174N)(D180N) 600 20 1.5 0.07 0.8
1(S191A/C193S)1(L9S)(D174N)(D180N) 780 20 1.6 0.06 1.1
1(S191A/C193Cah)1(L9S)(D174N)(D180N) 800 40 1.5 0.05 2
1(S191A/C193(N-methyl Cys))1(L9S)(D174N)(D180N) 500 20 1.5 0.07 2.2
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loop F residue that corresponds to Asp-174/Asp-180 is far
from theC loop of the adjacent subunit, and in the cryoelectron
microscopy structures of Torpedo nAChR, the residue is over
15 Å from the C loop (55, 56).
Given these data, what then is the functional role of the Cys-
192-Cys-193 vicinal disulfide of nAChR  subunits? Here we
present a speculative model. An early mutagenesis study of the
Torpedo nAChR indicated that both the C192S and the C193S
mutantswere unresponsive to high concentrations ofACh (17).
However, DTT reduction of the vicinal disulfide produced only
partial diminution of receptor function (6), and alkylation of
one of these cysteines by bromoacetylcholine (8) or QBr (16)
reinstates partial function despite the absence of the vicinal
disulfide. Here we also find that in mouse muscle and several
neuronal nAChRs, conventional mutations at Cys-192/Cys-
193, although certainly loss-of-function, do produce functional
receptors. In the present case, C192A and C193A are both loss-
of-function, but the magnitudes of the effects (2.0 and 1.7 kcal/
mol with the1S191A backgroundmutation) are less than seen
with the backbone mutations (2.9 and 3.0 kcal/mol), for which
the disulfide linkage is intact.
We propose that the role of the vicinal disulfide is to shape
the structure of the  turn between Tyr-190 and Cys-193. The
resultant distorted  turnmay then help position the backbone
NH of Ser-191 for formation of the second hydrogen bond.
Such a model is supported by the observation that backbone
mutations at Cys-193 are strongly loss-of-function, suggesting
that backbone positioning in this  turn is critical for receptor
function.
We noted above that the  turn seen in AChBP structures is
substantially distorted from idealized dihedral angle values for a
Type I  turn. Quantummechanical calculations (see details in
the supplementalmaterial) establish that reducing the disulfide
does indeed allow the  turn to relax toward a more typical
geometry. This structural change impacts the energetic
strength of the  turn hydrogen bond only modestly (0.3–0.4
kcal/mol), but it does alter the positioning of the peptide link-
age between Tyr-190 and Ser-191. Thus, we propose that the
essential consequence of the distortion of the turn induced by
the disulfide is not the energetic weakening of the turn hydro-
gen bond, but rather the positioning of Ser-191 in an orienta-
tion that is favorable for interaction with Asp-174/Asp-180.
Our gating model is thus as follows. In the closed state of the
receptor, the turn hydrogen bond is formed, but the intersub-
unit hydrogen bond (Ser-191 to Asp-174/Asp-180) is not
(consistent with the AChBP crystal structures). The  turn
hydrogen bond is essential to proper formation of the agonist
binding site (recall that Tyr-190 is residue C1 of the highly
conserved cluster of aromatic amino acids that delineate the
agonist binding site). Activation involves formation of the
intersubunit hydrogen bond, an event that is facilitated by
proper positioning of the backbone NH of Ser-191 by the vici-
nal disulfide and the  turn hydrogen bond. The two hydrogen
bonds should be mutually reinforcing, making the amide a
stronger hydrogen bond acceptor and donor, and so in our
model, the driving force formovement of the F loop (containing
Asp-174/Asp-180) is the formation of a network of hydrogen
bonds. As discussed elsewhere (48), this structural change at
the subunit interface then contributes to an early phase of the
conformational wave of receptor gating.
Note that our conventional mutations of Cys-192 and Cys-
193, both of which are loss-of-function, are consistent with this
model. The C192A and C193A mutants remove the disulfide
and allow the  turn to relax to a more typical conformation
(mirrored in the calculations). With the  turn relaxed, the
backbone NH of Ser-191 is not positioned optimally to form a
hydrogen bond with Asp-174/Asp-180, resulting in a loss of
receptor function. The critical role of the peptide bond is fur-
ther supported by our observation that disruption of the vicinal
disulfide (C193A) perturbs the hydrogen bond network in a
much more subtle manner than removal of the hydrogen bond
donor of Cys-193. Other Cys-loop receptors lack the vicinal
disulfide of the nAChR  subunit, and it will be interesting to
see whether the turn and intersubunit hydrogen bond survive
in a different environment.
The vicinal disulfide has a unique historical connection to
Asp-174/Asp-180.Czajkowski et al. (11, 12, 14, 57) linked the
reduced cysteine side chain at position 193 to Asp-174/
Asp-180 with a 9 Å cross-linker. Mutation of the aspartate
resulted in a large loss of receptor function, leading to the sug-
gestion that the negative charge of the aspartate side chain
interacts directly with the positive charge of the agonist. Sub-
sequentmutagenesis studies showed that the positive charge of
agonists makes a cation- interaction to a conserved trypto-
phan (32, 58) and not a direct interaction with the aspartate.
Crystallographic studies of AChBP supported the cation-
interaction and revealed that Asp-174/Asp-180 is positioned
far from the agonist binding site (24). Single channel studies
from the early 2000s suggested that the residue was important
for channel gating (and not binding) (59, 60); however, a role for
the aspartatewas only recently discovered. In 2008,we reported
thatAsp-174/Asp-180 is amember of an important intersub-
unit hydrogen bond linking the F and C loops and contributing
to channel gating (48). We now report an additional, larger
group of hydrogen bonds once again linking the vicinal disul-
fide to this important residue.
In summary, our mutagenesis studies unambiguously estab-
lish, through mutant cycle analysis, a hydrogen-bonding net-
work, beginning at the backbone NH of the Cys-192-Cys-193
disulfide, through the backbone amide linkage between Tyr-
190-Ser-191, and across the subunit interface to the side chain
of Asp-174/Asp-180. Based on this, we present a speculative
model in which the transition of the receptor from the closed to
the open state involves formation of a network of tandem
hydrogen bonds. In this model, the vicinal disulfide of the 
subunit distorts the C loop -turn to better position the back-
bone NH of Ser-191 for optimal formation of an intersubunit
hydrogen bond.
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